000
| 03063nam 2200553zi 4500 |
---|
001 | 9.914600 |
---|
003 | CaOODSP |
---|
005 | 20240208082111 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 220818t20222022onc ob f000 0 eng d |
---|
020 | |a9780660451244 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
045 | |ay2y2 |
---|
086 | 1 |aH14-410/2022E-PDF |
---|
245 | 00|a2022 Childhood COVID-19 Immunization Coverage Survey : |bmethodological report / |cprepared for the Public Health Agency of Canada. |
---|
264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022. |
---|
264 | 4|c©2022 |
---|
300 | |a1 online resource (55 pages) + |esummary (6 pages) + data tables (75 unnumbered pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Enquête sur la couverture vaccinale des enfants contre la COVID-19, 2022 : rapport méthodologique. |
---|
500 | |aPublication files replaced with new ones at request of author department, 3 November 2023. |
---|
500 | |a"Supplier name: Advanis Inc." |
---|
500 | |a"Contract number: 6D142-215412/001/CY. |
---|
500 | |a"Registration number: POR 130-21." |
---|
500 | |a"August 2022"--Page 2. |
---|
504 | |aIncludes bibliographical references. |
---|
650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada|xPublic opinion. |
---|
650 | 0|aCOVID-19 vaccines|zCanada|xPublic opinion. |
---|
650 | 0|aInfluenza|xVaccination|zCanada|xPublic opinion. |
---|
650 | 0|aInfluenza vaccines|zCanada|xPublic opinion. |
---|
650 | 0|aVaccination of children|zCanada|xPublic opinion. |
---|
650 | 0|aPublic opinion|zCanada. |
---|
650 | 0|aParents|zCanada|xAttitudes. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
710 | 2 |aAdvanis (Firm), |econsultant. |
---|
775 | 08|tEnquête sur la couverture vaccinale des enfants contre la COVID-19, 2022 : |w(CaOODSP)9.914601 |
---|
794 | |tChildhood COVID-19 Immunization Coverage Survey (CCICS), 2023 : |w(CaOODSP)9.930019 |
---|
856 | 40|qPDF|s1.15 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-410-2022-eng.pdf|z(methodological report) |
---|
856 | 40|qPDF|s270 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-410-2022-1-eng.pdf|z(executive summary) |
---|
856 | 40|qPDF|s2.56 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/H14-410-2022-2-eng.pdf|z(data tables) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2022/130-21-e/POR-130-21-report.html|z(methodological report) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2022/130-21-e/summary/POR-130-21-summary.html|z(executive summary) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2022/130-21-e/index.html|z(complete dataset) |
---|